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ABSTRACT 
Human T-cell leukemia virus type-1 (HTLV-1) propagates within and between individuals via 
cell-to-cell transmission, and primary infection typically occurs across juxtaposed mucosal 
surfaces during breastfeeding and sexual intercourse. It is therefore likely that dendritic cells 
(DCs) are among the first potential targets for HTLV-1. However, it remains unclear how 
DCs contribute to virus transmission and dissemination in the early stages of infection. We 
show that an HTLV-1-infected cell line (MT-2) and naturally-infected CD4+ T-cells transfer 
p19+viral particles to the surface of allogeneic DCs via cell-to-cell contacts. Similarly 
organized cell-to-cell contacts facilitate DC-mediated transfer of HTLV-1 to autologous 
CD4+ T-cells. These findings shed light on the cellular structures involved in anterograde 
and retrograde transmission, and suggest a key role for DCs in the natural history and 
pathogenesis of HTLV-1 infection. 
 
 
INTRODUCTION 
Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma 
(ATLL), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and 
HTLV-1-associated infective dermatitis (Fuzii et al., 2014; McGill et al., 2012; Uchiyama et al., 1977). The most 
severe clinical manifestation is ATLL, an aggressive and usually fatal lymphoproliferative 
disorder that develops in 1–5% of HTLV-1-infected individuals, typically after decades of 
apparent latency (Gessain and Cassar, 2012).   
 
Primary infection occurs during intimate mucosal contact, suggesting a key role for 
dendritic cells (DCs) and/or Langerhans cells (LCs) in the transmission process (Shimauchi and 
Piguet, 2015)
. In line with this supposition, a number of studies have demonstrated that various 
DC subsets, including plasmacytoid DCs (pDCs), myeloid DCs (mDCs), and monocyte-
derived DCs (MDDCs), can be infected at low levels in vitro by both cell-free and cell-
associated HTLV-1 (Alais et al. 2015; Ceccaldi et al., 2006; Jain et al., 2009; Jones et al., 2008; Lambert et al., 2009; Martin-
Latil et al., 2012; Rizkallah et al., 2017; Valeri et al., 2010)
.  It has also been shown that HTLV-1-infected DCs 
can transfer the virus to target CD4+ T-cells (Jain et al., 2009; Jones et al., 2008). These results are 
supported by ex vivo studies of DC subsets isolated from HTLV-1-infected individuals 
(Hishizawa et al., 2004; Macatonia et al., 1992; Makino et al., 1999)
. Thus, DCs are thought to play a key role in 
the early stages of infection, acting as a pivotal reservoir of transmissible virions that 
facilitates the dissemination of HTLV-1 via clonally expanded CD4+ T-cells.  
 
Although DCs can be infected with HTLV-1 in a cell-free manner, efficient infection 
requires cell-to-cell contacts in the form of virological synapses (Igakura et al., 2003) and/or  
cellular conduits (Van Prooyen et al., 2010), potentially modulated by biofilm-like extracellular viral 
assemblies (Pais-Correia et al., 2010). HTLV-1-containing virological synapses are based on 
interactions between intercellular adhesion molecule-1 (ICAM-1) on the infected cell 
surface and leukocyte function-associated molecule-1 (LFA-1) on the target cell surface, 
which induce the accumulation of talin and polarization of the microtubule-organizing 
center (MTOC) towards the cell-to-cell contact zone (Igakura et al., 2003). Virological synapse 
formation can facilitate the transmission of HTLV-1 proteins and genomic RNAs to the 
target cell within two hours (Igakura et al., 2003). Viral particles also congregate transiently in 
carbohydrate-rich extracellular assemblies (Pais-Correia et al., 2010). These unique biofilm-like 
structures can be transferred rapidly between infected and target CD4+ T-cells (Pais-Correia et 
al., 2010)
. However, it is remains unclear whether virological synapses or biofilm-like 
extracellular viral assemblies are involved in DC-mediated transmission of HTLV-1.   
 
In this study, we used confocal and electron microscopy to show that cell-to-cell contacts 
mediate virus transfer between HTLV-1-infected CD4+ T-cells and the surface membrane 
of DCs. Moreover, Alu-PCR and high-throughput integration site analysis revealed little 
evidence for proviral integration in DCs. In addition, we show that DCs can transfer HTLV-
1 to autologous CD4+ T-cells in trans. Collectively, these findings demonstrate that cell-to-
cell contacts play a key role in DC-mediated transmission of HTLV-1. 
 
RESULTS 
HTLV-1-infected cells transfer viruses to immature DCs via cell-to-cell contacts 
Virological synapses facilitate the transmission of HTLV-1 from infected to uninfected 
CD4+T-cells (Igakura et al., 2003). However, little is known about the cell-to-cell contact 
structures that mediate viral transfer between HTLV-1-infected CD4+ T-cells and DCs. To 
address this issue, we first cultured primary human immature monocyte-derived DCs 
(iDCs) for 96 hr in the presence or absence of HTLV-1-producing T-cell line MT-2. 
Transmission electron microscopy (TEM) showed that iDCs formed virological synapse-
like contacts with MT-2 cells (Figure 1a). Moreover, scanning electron microscopy (SEM) 
demonstrated that iDCs adjacent to MT-2 cells formed reduced numbers of filopodia, some 
of which extended in prolonged tubes resembling filopodial bridges to contact the MT-2 
cells (Figure 1b). In contrast, iDCs cultured in the absence of MT-2 cells extended their 
filopodia to the periphery (Figure 1a and b).   
 
Next, we co-cultured iDCs with MT-2 cells for 48 hr and performed confocal 
immunofluorescence analysis. The images demonstrated that MT-2 cells expressed high 
surface levels of HTLV-1 p19 Gag within a carbohydrate-rich matrix identified using the 
Concanavalin A viruses were polarized toward the contact zones, indicating virological 
synapse formation (Figure 1d). Other images further showed that the transferred viruses 
remained close to the surface of iDCs (Figure 1e). 
 
Cell-to-cell contact is required for virus transmission between HTLV-1-infected 
cells and DCs 
To quantify HTLV-1 transmission from MT-2 cells to iDCs and lipopolysaccharide (LPS)-
matured DCs (mDCs), we co-cultured iDCs with or without MT-2 cells in the presence or 
absence of LPS. After 48 hr, we analyzed intracellular expression levels of p19 Gag in 
neuropilin-1 (NRP-1)+ CD25– Live/Dead– CD1a+ iDCs/mDCs by flow cytometry (Figure 
2a).  Cell viability was comparable between the two conditions (Figure 2b). The 
frequencies of p19+ CD1a+ iDCs were comparable across time points in the presence of 
MT-2 cells, whereas iDCs cultured in the absence of MT-2 cells were negative for p19 Gag 
(Figure 2c). In contrast, virus transmission to mDCs was significantly enhanced after 48 hr 
in the presence of LPS (Figure. 2d). Parallel assays conducted across transwell 
membranes demonstrated that cell-to-cell contacts were required to mediate efficient virus 
transmission (Figure. 2e). 
 
Naturally HTLV-1-infected CD4+ T-cells transfer viruses to DCs via cell-to-cell 
contacts 
MT-2 cells have a high proviral load (PVL) and do not necessarily recapitulate the 
physiological characteristics of CD4+ T-cells in vivo. To address this potential caveat, we 
prepared HTLV-1-infected CD4+ T-cells from five patients with ATLL, two patients with 
HAM/TSP, and two asymptomatic carriers of HTLV-1. Allogeneic CD4+ T-cells from 
healthy volunteers were used as negative controls. Intracellular p19 Gag was expressed at 
high levels in CD4+ T-cells isolated from some ATLL patients (case 1 and case 3) relative 
to CD4+ T-cells from other HTLV-1+ groups or healthy controls (Figure 3a, and b). In co-
culture experiments performed over 48 hr in the presence of LPS, p19 Gag was detected 
in mDCs incubated with highly infected CD4+ T-cells from an ATLL patient (case 1) 
(Figure 3c and d).  In contrast, no virus transmission was detected in the presence of 
CD4+ T-cells with low levels of intracellular p19 Gag (Figure 3d). Thus, ATLL tumor cells 
producing high levels of HTLV-1 can transfer virions to allogeneic DCs.   
 
To determine if HTLV-1-infected CD4+ T-cells with low levels of intracellular p19 Gag can 
transfer viruses to DCs, we performed similar experiments using confocal microscopy 
instead of flow cytometry. As expected, low virus producing CD4+ T-cells from ATLL (case 
2) and HAM/TSP (case 2) patients expressed p19+ viral particles and transferred them to 
thesurface of iDCs at the contact zone (Figure 3e, 3f). While, no p19+ viral particles were 
detected in healthy allogeneic CD4+ T-cells (Figure 3g). Thus, naturally infected CD4+ T-
cells expressing low levels of intracellular p19 Gag can transfer HTLV-1 to DCs.   
 
Cell-to-cell contacts with HTLV-1-infected T-cells lead to trans infection of DCs 
Next, we examined the possibility that p19+ viruses detected on the surface of DCs were 
produced de novo after transfer from MT-2 cells. The HTLV-1 transactivator protein Tax is 
not transferred from infected to target cells, but it is expressed in target cells after viral 
integration (Jones et al., 2008). We therefore analyzed intracellular expression levels of p19 Gag 
and Tax in NRP-1+ CD1a+ mDCs by flow cytometry. Our results showed that LPS-induced 
mDCs did not express intracellular Tax (Figure 4a and b).   
 
To confirm this finding, which suggests viral capture rather than productive infection, we 
used Alu-PCR to analyze the integration of HTLV-1 proviral DNA. After overnight co-
culture, iDCs were separated from MT-2 cells using CD25 MicroBeads (Figure 4c). No gag 
amplification signals were detected in genomic DNA from HTLV-1+ and control iDCs 
(Figure 4d, lanes 2, 3, 5, and 6). In contrast, genomic DNA extracted from MT-2 cells as a 
positive control yielded clear gag amplification signals (Figure 4d, lane 1). Similar results 
were obtained with samples from five different donors. Nonetheless, HTLV-1+ iDCs from 
donor 1 and donor 2 exhibited PVLs of 0.79 % and 4.16 %, respectively (Figure 4d). We 
therefore performed unique integration site (UIS) mapping by high throughput sequencing 
(HTS) (Meekings et al., 2008). We detected 33 (donor 1) and 36 (donor 2) UISs in total, more than 
half of which corresponded with known UISs in MT-2 cells.  Moreover, the nine most 
abundant UISs corresponded with known UISs in MT-2 cells (Figure 4e). Accordingly, 16 
UISs in donor 1 and 17 UISs in donor 2, all of which were singletons, did not match known 
UISs in MT-2 cells. The proportion of singletons was higher in iDCs compared with MT-2 
cells, and the corresponding oligoclonality index was lower (Figure 4e). In addition to 
previously known UISs in MT-2 cells, donor 1 and 2 shared two other common UISs 
(chromosome 2 at position 60971860 and chromosome 6 at position 138426919). Our 
HTS analysis therefore suggests that much of the measured PVL in iDCs corresponded 
with low numbers of passenger MT-2 integrants. Collectively, these data indicate that DCs 
capture HTLV-1, but are not productively infected with HTLV-1.  
 
DC-mediated HTLV-1 transfer to autologous CD4+ T-cells in trans 
 
To test the idea that, DCs can re-transfer viruses to CD4+ T-cells in trans, we co-cultured 
HTLV-1+ iDCs/mDCs with uninfected autologous CD4+ T cells for 3 hr or 48 hr and 
measured the frequencies of p19+ CD4+ T-cells in the CD3+ CD4+ and DC-SIGN– CD25– 
populations (Figure 5a). No p19+ CD4+ T-cells were detected after co-culture with 
uninfected DCs (Figure 5a). In contrast, HTLV-1+ iDCs and HTLV-1+ mDCs both 
transferred virus to uninfected autologous CD4+ T-cells within 3 hr (Figure 5a). Thus, cell-
to-cell contacts contribute to DC-mediated HTLV-1 transfer to CD4+ T-cells.   
 
To confirm these findings, we used confocal and electron microscopy to visualize DC-
mediated transfer of HTLV-1 to CD4+ T-cells. TEM showed that HTLV-1+ iDCs formed 
reduced numbers of filopodia in the presence of HTLV-1+ MT-2 cells, but were capable of 
making intimate contacts with CD4+ T-cells (Figure 5b left panel). SEM also demonstrated 
that CD4+ T-cells contacted the surface membranes of HTLV-1+ iDCs (Figure 5b right 
upper and lower panel). After 48 hr, HTLV-1+ iDCs formed cell-to-cell contacts with 
autologous CD4+ T-cells via filopodial extensions (Figure 5c). In agreement with our flow 
cytometric analysis, the confocal images further revealed that p19+ viral particles were 
transferred from DCs to CD4+ T-cells within 3 hr (Figure 5d, 5f). Moreover, p19+ viral 
particles were no longer detectable in the DC-T-cell contact zone after 48 hr, instead 
localizing to the T-cell side of the contact zone or the T-cell surface (Figure 5e, 5g). In 
contrast to HTLV-1+ iDCs, control iDCs formed numerous filopodia and also formed 
contacts with CD4+ T-cells. No p19+ viral particles were detected in control mDCs. 
Collectively, these data show that cell-to-cell contacts contribute to DC-mediated HTLV-1 
transfer to CD4+ T-cells. 
 
 
DISCUSSION 
In this study, we show that cell-to-cell contacts facilitate the bidirectional transfer of HTLV-
1 between CD4+ T-cells and DCs. This process is far more efficient than cell-free 
transmission, and does not require productive infection of DCs. These findings suggest a 
key role for DCs in the acquisition and dissemination of HTLV-1.   
 
Previous studies have shown that HTLV-1 binds first to heparan sulfate proteoglycans and 
NRP-1, and then to glucose transporter type 1 (Glut-1), on target CD4+ T-cells (Ghez et al., 
2006; Jones et al. 2005; Lambert et al., 2009; Manel et al., 2003)
. In the case of DCs, HTLV-1 can bind also to 
DC-SIGN (Jain et al., 2009). We confirmed that both NRP-1 and DC-SIGN were highly 
expressed on DCs, but found that Glut-1 expression was lower compared with Jurkat cells 
or activated CD4+ T-cells. In addition, ICAM-1 was highly expressed on MT-2 cells and 
DCs, whereas LFA-1 was weakly expressed on MT-2 cells and DCs compared with 
activated CD4+ T-cells. Virological synapses between HTLV-1-infected CD4+ T-cells and 
DCs may therefore be structurally incomplete, which could explain the low efficiency of 
productive viral infection in target DCs. 
 
It has been reported previously that HTLV-1 virions are transferred at virological synapses 
via biofilm-like extracellular viral assemblies (Pais-Correia et al., 2010). Our findings provide 
support for this notion in terms of a synergistic interaction, but also suggest a degree of 
separability between these modes of transmission. The transfer of viral particles is not a 
specific property of DCs. To evaluate the efficiency of viral transfer by important cell types 
involved in HTLV-1 infection, we also performed HTLV-1 transfer assays by using both 
iDCs/mDCs and CD4+ T-cells to target autologous CD8+ T-cells. However, there was no 
significant difference between DCs-mediated and CD4+ T-cell-mediated virus transmission 
to autologous CD8+ T-cells. Thus, the transfer of HTLV-1 viral particles is not a specific 
property of dendritic cells. However, the data strongly suggests that DCs can transfer the 
virus with the same efficiency as CD4+ T-cells, which is thought to be a major virus 
transmitter.   
 
In contrast to our results, a recent using a different experimental model demonstrated that 
DCs can be infected by to HTLV-1 infected lines and that purified cell-free HTLV-1 in 
association with biofilms is more infectious than cell-free HTLV-1 in isolation (Alais et al., 2015). 
They also demonstrated that MDDCs were more susceptible to HTLV-1 infection than their 
autologous lymphocytes after contact with HTLV-1 infected and producing cell line, C91PL 
(Alais et al., 2015)
. Furthermore, the authors reported that HTLV-1 viral transmission from DCs 
to T-cells could result from transmission of newly synthesized virus from productively 
infected iDCs and mDCs (Rizkallah et al., 2017). For HTLV-1 infection and transmission model, 
the pretreatment of virus producing cell lines, MT-2 or C91PL cells with g irradiation or 
mitomycin C increases their efficiency to infect the target cells in vitro.  However, these 
sublethal conditions may also reshape the structure of extracellular viral assemblies (Pais-
Correia et al, 2010)
. In order to evaluate the nature of DC-T cells contacts, we used live MT-2 
cells, as commonly used cell line, as well as live naturally infected CD4+T-cells without 
any pretreatment in our study. However, it remains unclear whether or not bioflim-like 
extracellular viral assemblies exist in vivo, and further studies are therefore warranted to 
understand the role of these structures in the natural history of HTLV-1 infection.   
 
As in the case of HIV-1 (Geijtenbeek et al., 2000; McDonald et al., 2003; Turville et al., 2004), we found that LPS-
induced mDCs captured and transferred HTLV-1 to CD4+ T-cells in trans more efficiently 
than iDCs. The results were also consistent with the data from a recent paper 
demonstrating that LPS-induced mDCs increases HTLV-1 uptake (Rizkallah et al., 2017). HIV-1 
particles bind randomly to plasma membranes and eventually become concentrated into 
distinct, invaginated pockets on the surface of mDCs (Izquierdo-Useros et al., 2011). Sialic acid-
binding Ig-like lectin 1 (Siglec-1, CD169) is also highly expressed on mDCs and can bind 
HIV-1, facilitating viral spread to target CD4+ T-cells (Sewald et al., 2015). It is therefore possible 
that membrane trafficking effects and/or other surface receptors could play an important 
role in DC-mediated HTLV-1 transmission via biofilm-like extracellular viral assemblies.   
 
In addition to viral entry constraints, DCs are known to possess cell-specific restriction 
factors, which may further limit proviral integration. These include tripartite motif-5 alpha 
(TRIM-5 alpha), apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G or 
3F (APOBEC3G/3F), bone marrow stromal cell antigen-2 (BST-2, also known as tetherin, 
CD317, or HM1.24), and sterile alpha motif and hemidesmosome domain-containing 
protein 1 (SAMHD1) (Ahmed et al., 2013). SAMHD1 was identified as a critical post-entry 
restriction factor that limits HIV-1 infection in myeloid DCs, but not in LCs, via depletion of 
the cellular deoxynucleoside triphosphate pool, which inhibits reverse transcription of viral 
RNA (Czubala et al., 2016; Goldstone et al., 2011; Lahouassa et al., 2012). It has also been reported that 
SAMHD1 can limit HTLV-1 infection in monocytes (Sze et al. 2013), but this remains 
controversial (Gramberg et al., 2013). We also investigated whether down-regulation of SAMHD1 
can enhance HTLV-1 infection in DCs. However, we found equivalent frequencies of p19+ 
or Tax+ DCs and equivalent levels of phosphorylated interferon regulatory factor 3 (IRF3) 
in the presence or absence of SAMHD1. Although we cannot exclude the possibility of 
other viral restriction mechanisms, we suggest that HTLV-1 trans-infection of DCs plays a 
key role in the early stages of virus transmission.   
 
In conclusion, we show here that cell-to-cell contacts possibly involving biofilm-like 
extracellular viral assemblies mediate the bidirectional transfer of HTLV-1 between 
CD4+T-cells and the surface membrane of DCs. These findings suggest a key role for 
DCs in the early propagation of HTLV-1, akin to that described for HIV-1 (Piguet and Steinman, 
2007; Piguet et al., 2014)
. 
 
 
MATERIALS AND METHODS 
Cells and cell culture 
Buffy coats were obtained from healthy donors via the Welsh Blood Bank. CD14+ 
monocytes were isolated and differentiated to iDCs as described previously (Blanchet et al., 
2013)
. For use as autologous targets, CD4+ T-cells or CD8+ T-cells were purified using a 
CD4+ T-cell and CD8+ T-cell Isolation Kit II (Mitenyi Biotec), stimulated with 1 microg/ml 
phytohemagglutinin (PHA), and maintained in RPMI 1640 (Gibco) supplemented with 100 
U/mL recombinant human IL-2 (rhIL-2, Mitenyi Biotec). For use in ex vivo studies, 
uninfected and HTLV-1-infected CD4+ T-cells were purified as above and cultured 
overnight in supplemented RPMI 1640. The human T-cell acute lymphoblastic leukemia 
(T-ALL), Jurkat (E6.1), and MT-2 cell lines were maintained in supplemented RPMI 1640. 
HEK293T cells were cultured in DMEM (Gibco) supplemented with 10% fetal calf serum, 
100 IU/mL penicillin, and 100 ug/mL streptomycin. All cell lines used in this study tested 
negative for Mycoplasma. The MT-2 cell line was kindly provided by Prof. Toshiki 
Watanabe (University of Tokyo) and Prof. Charles Bangham (Imperial College London). 
 
HTLV-1 transfer from CD4+ T-cells to DCs 
On day 5 or 6 post-differentiation, 1 x 105 iDCs were cultured in round-bottom 96-well 
plates with 1 x 105 MT-2, Jurkat, or allogeneic CD4+ T-cells in 100 uL of IMDM with 
GlutMax (Gibco). mDCs were generated via the addition of LPS (1 mg/mL, InvivoGen). 
After 48 hr, cells were processed for flow cytometric analyses or confocal microscopy 
studies. In some experiments, cell populations were separated across transwell chambers 
in 24-well culture plates (6.5 mm Transwell with 0.4 um Pore Polyester Membrane Insert, 
Corning). 
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Figure 1. Virus transmission from HTLV-1-producing MT-2 cells to iDCs  
via cell-to-cell contacts.  
 
 
 
(a) TEM images of cell-to-cell contacts between iDCs and MT-2 cells, and control iDCs cultured in 
the absence of MT-2 cells. Scale bars = 1 mm. (b) SEM images of cell-to-cell contacts between 
iDCs and MT-2 cells, and control iDCs cultured in the absence of MT-2 cells. The highlighted area in 
left panel is enlarged in middle panel. Scale bars = 20 mm (left), 2 mm (middle), 10 mm (right). (c–e) 
Confocal immunofluorescence images of cell-to-cell contacts between iDCs and MT-2 cells. Lectin-
ConA (green), p19 Gag (red), CD3 (yellow), DAPI (nucleus, blue). Scale bars = 5 mm. TEM, 
transmission electron microscopy; SEM, scanning electron microscopy; iDCs, immature dendritic 
cells; ConA, Concanavalin A. 
 
  
Figure 2. Quantification of HTLV-1 transmission from MT-2 cells to 
iDCs/mDCs via cell-to-cell contacts.  
 
 
 
(a) iDCs were co-cultured for 48 hr with or without MT-2 cells in the presence or absence of LPS, 
and intracellular expression of p19 Gag in NRP-1+ CD25–Live/Dead– iDCs/mDCs was quantified 
by flow cytometry. (b) Comparison of cell viability across experimental conditions (n = 14). (c) 
Percentages of p19+ CD1a+ iDCs co-cultured for 24, 48, or 72 hr with or without MT-2 cells (n = 
3). (d, e) Percentages of p19+ CD1a+iDCs/ mDCs co-cultured for 48 hr with MT-2 cells in the 
presence or absence of LPS (n = 14) or in the presence or absence of a transwell membrane (n = 
2). Error bars indicate mean ± standard deviation. ***p < 0.005; ns, not significant. iDCs, immature 
dendritic cells; mDCs, mature dendritic cells; NRP-1, neuropilin-1; LPS, lipopolysaccharide 
 
  
Figure 3. Quantification of HTLV-1 transmission fromnaturally infected 
CD4+ T-cells to allogeneic DCs via cell-to-cell contacts.  
 
 
 
(a, b) Representative flow cytometry plots and composite data showing intracellular p19 Gag 
expression in CD4+ T-cells purified from HTLV-1-infected individuals (n = 7) and healthy donors (n 
= 4). (c, d) Representative flow cytometry plots and composite data showing intracellular p19 Gag 
expression in LPS-induced mDCs co-cultured for 48 hr with CD4+ T-cells purified from patients 
with ATLL (n = 5), HAM/TSP (n = 2), asymptomatic carriers of HTLV-1 (n = 2), and healthy donors 
(n = 4).  Error bars indicate mean ± standard deviation. (e-g) Confocal immunofluorescence 
images of cell-to-cell contacts between iDCs and CD4+ T-cells purified from a patient with ATLL, 
HAM/TSP, and healthy donor. Lectin-ConA (green), p19 Gag (red), CD3 (yellow), DAPI (nucleus, 
blue). Scale bars = 5 mm. DCs, dendritic cells; LPS, lipopolysaccharide; mDCs, mature dendritic 
cells; NRP-1, neuropilin-1; ConA, Concanavalin A 
 
 
  
Figure 4. Trans-infection of DCs via cell-to-cell contacts with HTLV-1-
infected T-cells.  
 
 
 
(a, b) Representative flow cytometry plots and composite data showing percentages of p19+ or 
Tax+ mDCs co-cultured with or without MT-2 cells (n = 3). Error bars indicate mean ± standard 
deviation. (c) Representative flow cytometry plots showing purification of HTLV-1+ iDCs from MT-2 
cells using CD25 MicroBeads. (d) Representative Alu-PCR analysis of HTLV-1 proviral integration 
in genomic DNA extracted from HTLV-1+ iDCs (lanes 3 and 6), control iDCs (lanes 2 and 5), and 
MT-2 cells (lane 1). No template controls are shown in lanes 4 and 7. HTLV-1 proviral load (PVL) 
in HTLV-1+ iDCs was determined by quantitative real-time PCR. (e) Pie charts showing the relative 
abundance of unique integration sites (UISs) in MT-2 cells and HTLV-1+ iDCs isolated after co-
culture with MT-2 cells. Each pie slice represents a single observed clone. Colors indicate the most 
abundant identical clones.  The oligoclonality index (OCI) is a measure of clonal distribution, 
ranging from 0 (polyclonal with all clones contributing equally to PVL) to 1 (monoclonal with all 
infected cells belong to a single clone). DCs, dendritic cells; mDCs, mature dendritic cells; iDCs, 
immature dendritic cells. 
  
Figure 5. Quantification of DC-mediated HTLV-1 transfer toward autologous 
CD4+T-cells via cell-to-cell contacts.  
 
 
 
(a) Percentages of p19+ CD3+ CD4+ CD25– DC-SIGN– cells after co-culture with control iDCs, 
control mDCs, HTLV-1+ iDCs, or HTLV-1+ mDCs for 3hr or 48 hr. Data were obtained from two to 
three independent experiments. Error bars indicate mean ± standard deviation. (b, c) TEM and SEM 
images of cell-to-cell contacts between HTLV-1+ iDCs and autologous CD4+ T-cells after co-culture 
for 3 hr or 48 hr. The boxed areas in upper panels are enlarged in lower panels. Scale bars = 5 mm 
(left in b), 4 mm (right upper in b), 2 mm (right lower in b), 2 mm (right upper in c), 1 mm (right lower 
in c), 5 mm (left upper in c), 3 mm (left lower in c). (d-g) Confocal immunofluorescence images of 
cell-to-cell contacts between HTLV-1+ iDCs/ mDCs and autologous CD4+ T-cells after co-culture for 
3 hr or 48 hr. Lectin-ConA (green), p19 Gag (red), CD3 (yellow), DAPI (nucleus, blue). White arrows 
indicate transferred viral assemblies. Scale bars = 5 mm. iDCs, immature dendritic cells; mDCs, 
mature dendritic cells; TEM, transmission electron microscopy; SEM, scanning electron microscopy; 
ConA, Concanavalin A. 
